For any further information
Who we are
Resono Ophthalmic is an Italian company that produces highly innovative therapeutic devices for the eye-care domain. The key feature of these devices is the exploitation of Quantum Molecular Resonance (QMR®), a patented technique capable of stimulating the natural cellular and tissue regeneration via low-power high-frequency electric fields.
Our Mission
Our mission is to contribute to improving the quality of patient’s life by providing ground-breaking solutions that effectively treat a range of eye syndromes and diseases.Reinvent Dry Eye Treatment
Rexon-Eye is a non-invasive device that provides durable treatment for all forms of dry eye syndromes. It works by applying low-power high-frequency electric fields, capable of stimulating the metabolism and natural regeneration of cells.
The treatment addresses all types of the dry eye syndromes, both evaporative and hypo-secretive, as evidenced by several subjective and objective measurements.
Newsroom
RESONO OPHTHALMIC at ESCRS 2022 in Milan
RESONO OPHTHALMIC will attend the 40th Congress of the ESCRS in Milan, from 16th to 20th September...
Resono Ophthalmic at EuDES congress 2022, Paris
Resono Ophthalmic will enjoy a wide coverage at the forthcoming EuDEC (Paris, June 10-11). Giulio...
Our website is now enriched with new content and new pages.
For some weeks now, the Resono Ophthalmic site has been enriched by new pages and more in-depth...